electroCore, Inc. (NASDAQ:ECOR - Get Free Report) was up 14.6% on Thursday . The company traded as high as $7.69 and last traded at $7.55. Approximately 116,784 shares were traded during trading, an increase of 47% from the average daily volume of 79,651 shares. The stock had previously closed at $6.59.
Analyst Upgrades and Downgrades
ECOR has been the topic of several recent analyst reports. HC Wainwright restated a "buy" rating and set a $25.00 price objective on shares of electroCore in a report on Thursday, March 13th. LADENBURG THALM/SH SH dropped their target price on electroCore from $28.00 to $26.00 and set a "buy" rating on the stock in a report on Thursday, March 13th.
Check Out Our Latest Stock Report on electroCore
electroCore Price Performance
The company has a market capitalization of $52.94 million, a PE ratio of -4.02 and a beta of 0.83. The business's 50 day simple moving average is $8.84 and its 200 day simple moving average is $12.23.
Insider Transactions at electroCore
In other news, Director Thomas J. Errico bought 6,000 shares of electroCore stock in a transaction dated Monday, March 17th. The stock was bought at an average price of $8.10 per share, for a total transaction of $48,600.00. Following the purchase, the director now owns 256,401 shares of the company's stock, valued at approximately $2,076,848.10. The trade was a 2.40 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 19.70% of the company's stock.
Hedge Funds Weigh In On electroCore
Institutional investors have recently made changes to their positions in the stock. Renaissance Technologies LLC grew its position in electroCore by 80.6% during the fourth quarter. Renaissance Technologies LLC now owns 131,786 shares of the company's stock valued at $2,136,000 after acquiring an additional 58,800 shares during the period. Marshall Wace LLP purchased a new position in electroCore in the fourth quarter valued at about $438,000. Jane Street Group LLC bought a new stake in shares of electroCore in the fourth quarter worth $278,000. NewEdge Advisors LLC acquired a new stake in shares of electroCore in the 4th quarter valued at about $274,000. Finally, DnB Asset Management AS acquired a new position in shares of electroCore in the 4th quarter worth approximately $180,000. 26.74% of the stock is owned by institutional investors and hedge funds.
electroCore Company Profile
(
Get Free Report)
electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
Featured Articles
Before you consider electroCore, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and electroCore wasn't on the list.
While electroCore currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
